Trials / Available
AvailableNCT04360005
Managed Access Programs for ABL001, Asciminib
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registration form is to list all Managed Access Programs (MAPs) related to ABL001, asciminib
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Asciminib | Patients receive Asciminib |
Timeline
- First posted
- 2020-04-24
- Last updated
- 2025-12-05
Source: ClinicalTrials.gov record NCT04360005. Inclusion in this directory is not an endorsement.